SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-000432
Filing Date
2022-01-05
Accepted
2022-01-05 17:04:11
Documents
17
Period of Report
2021-12-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-8k_20211229.htm   iXBRL 8-K 52791
2 EX-10.1 sprb-ex101_7.htm EX-10.1 23142
3 EX-10.2 sprb-ex102_6.htm EX-10.2 85440
4 EX-99.1 sprb-ex991_8.htm EX-99.1 18174
5 GRAPHIC gmad514xubdi000001.jpg GRAPHIC 4250
6 GRAPHIC gun0ounw1qm2000001.jpg GRAPHIC 7871
  Complete submission text file 0001564590-22-000432.txt   357673

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sprb-20211229.xsd EX-101.SCH 5721
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sprb-20211229_lab.xml EX-101.LAB 20078
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sprb-20211229_pre.xml EX-101.PRE 11961
11 EXTRACTED XBRL INSTANCE DOCUMENT sprb-8k_20211229_htm.xml XML 3691
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 22512138
SIC: 2834 Pharmaceutical Preparations